Abstract | PURPOSE: METHODS: RESULTS: A visually judged complete response was achieved in 42% (8/19) of the basal cell carcinomas and in 100% of the T-cell lymphoma lesions (3/3). Partial tumour response was seen in 42% (8/19) and no response in 16% (3/19) of the basal cell carcinomas. The median follow-up time was 12 months. No, or very little scarring and loss of cilia were induced by the treatment. CONCLUSION:
|
Authors | I Wang, B Bauer, S Andersson-Engels, S Svanberg, K Svanberg |
Journal | Acta ophthalmologica Scandinavica
(Acta Ophthalmol Scand)
Vol. 77
Issue 2
Pg. 182-8
(Apr 1999)
ISSN: 1395-3907 [Print] Denmark |
PMID | 10321535
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Photosensitizing Agents
- Aminolevulinic Acid
|
Topics |
- Administration, Topical
- Adult
- Aged
- Aged, 80 and over
- Aminolevulinic Acid
(administration & dosage, therapeutic use)
- Carcinoma, Basal Cell
(drug therapy, pathology)
- Eyelid Neoplasms
(drug therapy, pathology)
- Female
- Follow-Up Studies
- Humans
- Lasers
- Lymphoma, T-Cell
(drug therapy, pathology)
- Male
- Middle Aged
- Photochemotherapy
- Photosensitizing Agents
(administration & dosage, therapeutic use)
- Skin Neoplasms
(drug therapy, pathology)
- Treatment Outcome
|